Publications | Lund University Publications

1 – 6 of 6

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Dahl%C3%A9n%2C+Torsten%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Dahl%C3%A9n%2C+Torsten%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2022
Mark The frequency of misattributed paternity in Sweden is low and decreasing : A nationwide cohort study
Dahlén, Torsten ; Zhao, Jingcheng ; Magnusson, Patrik K.E. ; Pawitan, Yudi ; Lavröd, Jakob and Edgren, Gustaf (2022) In Journal of Internal Medicine 291(1). p.95-100
- Contribution to journal › Article
Mark Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors : Follow-up of patients diagnosed 2002–2017 in a complete coverage and nationwide agnostic register study
Dahlén, Torsten ; Edgren, Gustaf ; Ljungman, Per ; Flygt, Hjalmar ; Richter, Johan ^LU ; Olsson-Strömberg, Ulla ; Wadenvik, Hans ; Dreimane, Arta ; Myhr-Eriksson, Kristina and Zhao, Jingcheng , et al. (2022) In American Journal of Hematology 97(4). p.421-430
- Contribution to journal › Article
2021
Mark An agnostic study of associations between abo and rhd blood group and phenome-wide disease risk
Dahlén, Torsten ; Clements, Mark ; Zhao, Jingcheng ; Olsson, Martin L. ^LU and Edgren, Gustaf (2021) In eLife 10.
- Contribution to journal › Article
Mark Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population-based Swedish chronic myeloid leukaemia registry
Flygt, Hjalmar ; Sandin, Fredrik ; Dahlén, Torsten ; Dremaine, Arta ; Lübking, Anna ^LU ; Markevärn, Berit ; Myhr-Eriksson, Kristina ; Olsson, Karin ; Olsson-Strömberg, Ulla and Själander, Anders , et al. (2021) In British Journal of Haematology 193(5). p.915-921
- Contribution to journal › Article
2017
Mark Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register
Söderlund, Stina ; Dahlén, Torsten ; Sandin, Fredrik ; Olsson-Strömberg, Ulla ; Creignou, Maria ; Dreimane, Arta ; Lübking, Anna ^LU ; Markevärn, Berit ; Själander, Anders and Wadenvik, Hans , et al. (2017) In European Journal of Haematology 98(1). p.57-66
- Contribution to journal › Article
2016
Mark Cardiovascular events associated with use of tyrosine kinase inhibitors in chronic myeloid leukemia
Dahlén, Torsten ; Edgren, Gustaf ; Lambe, Mats ; Höglund, Martin ; Björkholm, Magnus ; Sandin, Fredrik ; Själander, Anders ; Richter, Johan ^LU ; Olsson-Strömberg, Ulla and Ohm, Lotta , et al. (2016) In Annals of Internal Medicine 165(3). p.161-166
- Contribution to journal › Article

your query:: Remove author: Dahlén, Torsten